ALKERMES | ALKS - Attività

Prezzo Delle Azioni
33.70
Cambio Giornaliero
-0.01 -0.03%
Mensile
-4.69%
Annuale
10.20%
Q2 Previsione
32.32




Attività Cambiamento Data
AbbVie USD 133.96B 62M 2025-12
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
ALKERMES USD 2.49B 157.48M 2025-12
Amgen USD 92.5B 1.92B 2026-03
Biogen USD 29.48B 43.6M 2026-03
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Coherus Biosciences USD 258.34M 258.18M 2025-12
Eli Lilly USD 116.58B 4.1B 2026-03
Gilead Sciences USD 59.02B 490M 2025-12
Heron Therapeutics USD 255.88M 6.93M 2025-12
Ionis Pharmaceuticals USD 3.45B 74M 2026-03
J&J USD 200.89B 1.68B 2026-03
Malin Corporation EUR 198.5M 70.1M 2024-12
Merck USD 136.87B 7.32B 2025-12
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Otsuka Holdings JPY 4.21T 11.63B 2026-03
Ovoca Bio EUR 1.66M 9.75M 2025-06
Pfizer USD 208.73B 2.64B 2025-09
Regeneron Pharmaceuticals USD 40.87B 310.1M 2026-03
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12